DavidLawrenceBartlettMD
General Surgery • Pittsburgh, PASurgical Oncology (Other than Breast)
Chair, AHN Cancer Institute
Dr. Bartlett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
314 E North Ave
1st Floor
Pittsburgh, PA 15212Phone+1 833-246-2323Fax+1 412-442-2323
Education & Training
University of Pennsylvania Health SystemResidency, Surgery, 1987 - 1993
McGovern Medical School at UTHealthClass of 1987
University of Texas Medical School at HoustonClass of 1987
Certifications & Licensure
NY State Medical License 1993 - 2025
PA State Medical License 1989 - 2024
MD State Medical License 1995 - 2002- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Pittsburgh Magazine Castle Connolly, 2006-2011
- Join now to see all
Clinical Trials
- Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas Start of enrollment: 2000 Sep 01
- Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer Start of enrollment: 2008 Jan 01
- A Multi-Center, Open-Label, Randomized Phase II Trial to Evaluate Hematologic Toxicities After Hyperthermic Intraperitoneal Chemotherapy (HIPEC)With Oxaliplatin or Mitomycin C in Patients With Primary Appendiceal Tumors. Start of enrollment: 2009 May 01
- Join now to see all
Publications & Presentations
PubMed
- ASO Visual Abstract: Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Disse...Edward A Levine, Heidy Cos, Konstantinos I Votanopoulos, Perry Shen, Greg Russell
Annals of Surgical Oncology. 2025-02-01 - Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination.Edward A Levine, Heidy Cos, Konstantinos I Votanopoulos, Perry Shen, Greg Russell
Annals of Surgical Oncology. 2025-02-01 - Correction: Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies.Patrick L Wagner, Chelsea M Knotts, Vera S Donneberg, Neda Dadgar, Christian X Cruz Pico
Annals of Surgical Oncology. 2025-01-18
Journal Articles
- Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion Is Feasible and Offers Survival Benefit in Select Patients with Peritoneal MetastasesDavid L Bartlett, Filip Bednar, Reetesh K Pai, Heather L Jones, James F Pingpank, Matthew P Holtzman, Herbert J Zeh, Annals of Surgical Oncology
- Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal MalignanciesMatthew P Holtzman, James F Pingpank, David L Bartlett, Herbert J Zeh, Annals of Surgical Oncology
- Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology FellowshipMelissa E Hogg, David L Bartlett, Herbert J Zeh, Amer H Zureikat, Annals of Surgical Oncology
- Join now to see all
Press Mentions
Cancer Screening Clinic Being Held at Allegheny General Hospital Next MonthJanuary 15th, 2025- New AHN Cancer Institute Recruit Brings Unique Expertise in Benefits of Exercise and Nutrition for Improving Cancer Treatment OutcomesAugust 30th, 2022
- Illumina and Allegheny Health Network to Assess in-House Comprehensive Cancer Genomic Profiling to Enhance Patient CareMay 19th, 2022
- Join now to see all
Grant Support
- Multimodality Approach To Hepatic Colorectal MetastasesNational Cancer Institute2010–2012
- Improving Vaccinia For Peritoneal Tumors: Enhanced Distribution &Immune EvasionNational Cancer Institute2011
- Staff InvestigatorsNational Cancer Institute2010–2011
- Tumor-Selective Oncolytic Vaccinia Virus And Alphadc1-Based Vaccine As A CombinatNational Cancer Institute2009–2011
- Postdoctoral Research Training In Biotherapy Of CancerNational Cancer Institute2006–2011
- Isolated Hepatic Perfusion With OxaliplatinNational Cancer Institute2007
- Development Of A Tumor Selective Replicating VacciniaNational Cancer Institute2004–2007
- Islolated Hepatic Perfusion With OxaliplatinNational Cancer Institute2006
- Tumor Selective Viral Vectors And Surgical ProceduresDivision Of Clinical Sciences - Nci2001
- Development Of Tumor Selective Viral Vectors And Development Of Surgical ProceduDivision Of Clinical Sciences - Nci2000
- Development Of Tumor Selective Viral Vectors And Complex Surgical Procedures ForDivision Of Clinical Sciences - Nci1999
- Suicide Gene Therapy In The Regional Treatment Of CancerDivision Of Clinical Sciences - Nci1996–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
